. Author manuscript; available in PMC: 2009 Nov 1.

Published in final edited form as: Exp Hematol. 2008 Aug 23;36(11):1480–1486. doi: 10.1016/j.exphem.2008.05.006

Table 2.

Comparison of clinical features of clonally dominant versus nondominant PV patients in 50 patients not receiving chemotherapy.

	Clonally dominant PV	Clonally nondominant PV	P value
Number	26	24
Disease duration (years)	8.1 (0–25)	3.0 (0–10)	0.007
Platelet count (K/cu mm)	526 (38–1239)	663 (291–1269)	0.12
Reticulocyte count (K/cu mm)	102.3 (45.5–232.2)	94.6 (62.2–138.2)	0.43
Spleen size (centimeters below the costal margin)	4.3 (0–14)	1.3 (0–14)	0.05
White cell count (K/cu mm)	20.4 (4.5–47.7)	13.4 (5.8–37.2)	0.01
Neutrophil allele burden (%)	68.1 (40–100)	62.5 (35–100)	0.29
CD34 cell allele burden (%)	70.5 (35–100)	36.3 (11–87)	<.001

All values are expressed as means and ranges (parentheses).